Jump Financial’s Xenon Pharmaceuticals XENE Stock Holding History

Jump Financial’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.7M	Buy	260,730 +104,954	+67%	+$5.83M	0.13%	164
2026 Q1	$9.06M	Buy	155,776 +124,789	+403%	+$5.75M	0.12%	195
2025 Q4	$1.39M	Buy	30,987 +24,487	+377%	+$1.03M	0.02%	839
2025 Q3	$261K	Sell	6,500 -10,491	-62%	-$369K	﹤0.01%	1555
2025 Q2	$532K	Buy	+16,991	New	+$554K	0.01%	1215
2024 Q4	–	Sell	-45,000	Closed	-$1.77M	–	2066
2024 Q3	$1.77M	Sell	45,000 -3,166	-7%	-$128K	0.04%	571
2024 Q2	$1.88M	Buy	48,166 +2,087	+5%	+$83.4K	0.04%	580
2024 Q1	$1.98M	Buy	46,079 +22,079	+92%	+$1.02M	0.05%	450
2023 Q4	$1.11M	Buy	+24,000	New	+$848K	0.04%	664
2023 Q1	–	Sell	-7,725	Closed	-$305K	–	2117
2022 Q4	$305K	Sell	7,725 -45,575	-86%	-$1.66M	0.02%	1039
2022 Q3	$1.92M	Buy	+53,300	New	+$1.92M	0.07%	394
2022 Q2	–	Sell	-30,101	Closed	-$920K	–	2068
2022 Q1	$920K	Sell	30,101 -1,199	-4%	-$35.9K	0.04%	555
2021 Q4	$978K	Buy	+31,300	New	+$935K	0.06%	394

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Jump Financial's XENE Position: Q2 2026 in Review

Jump Financial increased its Xenon Pharmaceuticals (XENE) stake by 67% in Q2 2026, buying an estimated $5.83M and bringing the position to 260,730 shares worth $15.7M. The position accounts for 0.13% of the portfolio, ranked #164.

Jump Financial first reported a position in XENE in Q4 2021 and has held it in 13 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Jump Financial held 260,730 shares of Xenon Pharmaceuticals worth $15.7M as of Q2 2026.
Jump Financial bought 104,954 Xenon Pharmaceuticals shares in Q2 2026, an estimated $5.83M.
Xenon Pharmaceuticals made up 0.13% of Jump Financial's portfolio in Q2 2026, its #164 holding.
Jump Financial first reported a position in Xenon Pharmaceuticals in Q4 2021 and has held it in 13 quarters since.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.